Amyotrophic Lateral Sclerosis Therapy Development Institute
The ALS Therapy Development Institute is a non-profit biotechnology research organization focused on finding treatments for amyotrophic lateral sclerosis. With a staff including more than 30 scientists, it operates a research and development program centered on ALS. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Amyotrophic Lateral Sclerosis Therapy Development Institute, United States, covering academic research published from 2001 to 2025. Read More.
Open Access Percentage
83%
Total
Publications
101
Total Open
Publications
84
Total
Citations
5.7K
Open Access
Percentage
83%
Total
Publications
101
Total Open
Publications
84
Total
Citations
5.7K
Breakdown
Publisher Open
30%
Both
37%
Other Platform Open
16%
Closed
17%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 39%
26
Hybrid 23%
15
No Guarantees 38%
25
Other Platform Open
Domain 68%
36
Institution 45%
24
Preprint 21%
11
Public 11%
6
Other Internet 6%
3
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 36 |
doaj.org OAI-PMH Repository | Institution | 17 |
Figshare | Public | 6 |
medRxiv | Preprint | 4 |
California Digital Library | Institution | 3 |
bioRxiv | Preprint | 3 |
Europe PMC | Domain | 2 |
DOI | Other Internet | 2 |
ChemRxiv | Preprint | 2 |
wur.nl OAI-PMH Repository | Institution | 1 |